What question did the researchers ask?
The meta-analysis pooled trials of hormone replacement therapy for menopausal symptoms, examining symptom scores, quality of life, vaginal health, bone density, blood lipids and adverse events.
What did they actually find?
HRT was associated with improved menopause symptom and quality-of-life scores, vaginal measures and bone-density outcomes. Pooled treatment-emergent adverse events did not differ significantly from controls.
What should you keep in mind?
Formulation, route, dose, age, timing and personal medical risks matter. A pooled analysis cannot decide suitability for an individual, and this menopause evidence does not automatically apply to testosterone treatment or every hormone-related concern.
What does this mean for a Highfield consultation?
Benefits and risks depend on symptoms, health history, formulation and timing; assessment remains essential. We consider that finding alongside independent guidance, your medical history, examination and priorities. It can support a better-informed decision, but it cannot promise a personal result or decide whether treatment is suitable.
Explore Wellness consultations at Highfield ↗
